- Why Research
- Our Impact
- Get Involved
- About BCRF
- Research is the reason
- Contact Us
You are here
BCRF is proud to congratulate two Scientific Advisory Board members and two BCRF investigators who were recognized for their achievements.
In recognition of Men’s Health Week, BCRF is focusing on male breast cancer – a lesser-known subtype.
BCRF investigators develop checkpoint inhibitors to effectively treat breast cancer
The groundbreaking TAILORx Study is the largest trial of its kind with over 10,000 patients enrolled in 6 countries.
BCRF investigators try to understand the brain’s unique environment to prevent and treat brain metastasis.
An interview with BCRF researcher Dr. Anne McTiernan.
A BCRF researcher for two decades, Dr. Wigler shares his pioneering work in molecular biology.
BCRF investigator Kent Osborne discusses the successes, challenges and opportunities in treatment for HER2-positive breast cancer.
BCRF researcher Dr. Charles Perou has helped categorize TNBC tumors into 4 distinct molecular subtypes.